Jennifer Cann Views & Analysis Patient centricity in pharma: Predictions for 2020 and beyon... pharmaphorum's Jennifer Cann looks at what trends from 2019 tell us about the future of patient centricity and how pharma can prepare themselves for the coming changes.
Views & Analysis Patient centricity in pharma: Predictions for 2020 and beyon... pharmaphorum's Jennifer Cann looks at what trends from 2019 tell us about the future of patient centricity and how pharma can prepare themselves for the coming changes.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
